GLUT-1 promotes glucose transport across the plasma membrane of mammalian cells, and GLUT-1 overexpression is a prognostic biomarker of cancer [40,41] and can be a potential target, as it has been shown to regulate cancer in several reports [42,43,44]. This evidence concerns the gene SLC2A1 and cancer.